Suppliers / Daewoong Pharmaceutical

Daewoong Pharmaceutical

South Korea Updated 9 July 2026

The public registers hold a second record for Daewoong Pharmaceutical. The fuller profile, with 2 active US DMFs and 4 valid CEPs, is at Daewoong. Figures on this page cover only this record.

Daewoong Pharmaceutical is a finished-dose manufacturer based in South Korea. It appears in 70 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), BPOM (ID) and ARCSA (EC). Its GMP standing is certified by BPOM (ID).

0
active US DMFs
0
valid CEPs
4
registered plants
70
filings across 11 regulators

Registered plants

Site FDA FEI
Gyeonggi-do, United Arab Emirates Not on file
Cheongju-si, United Arab Emirates Not on file
KAB. BEKASI, Indonesia Not on file
CHUNGCHEONGBUK-DO, South Korea Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 40 None
BPOM (ID) 8 8
ARCSA (EC) 6 None
NMPA (CN) 6 None
MINSA (CR) 3 None
EDE (AE) 2 None

Comparing suppliers?

Choose your molecules and target markets. Daewoong Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates